Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 5 of 5
EC Number Application Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.45drug development therapeutic interventions that potentiate BACE2 may prevent Alzheimer’s disease 686629
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.45medicine enzyme inhibition is a treatment of type 2 diabetes 753256
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.45medicine in patients with preclinical to late-stage Alzheimer's disease, including amnestic mild cognitive impairment, and age-matched controls, cases of frontotemporal dementia, and Down's syndrome, BACE2 protein and enzymatic activity increase as early as preclinical Alzheimer's disease and are found in neurons and astrocytes. Although the levels of total BACE2 mRNA are unchanged, the mRNA for BACE2 splice form C (missing exon 7) increases in parallel with BACE2 protein and activity. BACE1 and BACE2 are strongly correlated with each other at all levels. BACE2 is also elevated in frontotemporal dementia but not in Down's syndrome, even in patients with substantial amyloid beta deposition 733057
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.45medicine samples from frontal cortex of both Alzheimer's disease-affected individuals and age-matched controls show substantial total amounts of BACE2 protein and enzymatic activity. BACE2 activity does not change significantly in the brain of patients with Alzheimer's disease, and is not related to amyloid beta-peptide concentration 712811
Display the word mapDisplay the reaction diagram Show all sequences 3.4.23.45pharmacology the enzyme is a potential target for development of inhibitors in Alzheimer's disease therapy and treatment of Down syndrome 670020
Results 1 - 5 of 5